Details
Stereochemistry | RACEMIC |
Molecular Formula | C28H34O8 |
Molecular Weight | 498.5648 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=C(OCCCCCOC2=CC3=C(CCC(O3)C(O)=O)C=C2C(C)=O)C=CC(C(C)=O)=C1O
InChI
InChIKey=FGGYJWZYDAROFF-UHFFFAOYSA-N
InChI=1S/C28H34O8/c1-4-8-21-23(12-10-20(17(2)29)27(21)31)34-13-6-5-7-14-35-26-16-25-19(15-22(26)18(3)30)9-11-24(36-25)28(32)33/h10,12,15-16,24,31H,4-9,11,13-14H2,1-3H3,(H,32,33)
Molecular Formula | C28H34O8 |
Molecular Weight | 498.5648 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Ablukast is a benzopyran derivative, a leukotriene receptor antagonist with potential as an antiasthmatic agent. Ablukast antagonized he hypotensive effect of N-methyl leukotriene C4 and leukotriene C4 (LTC4). Ablukast also antagonized the effects induced by high doses of leukotriene D4 and E4. Receptors that preferentially bind LTC4 in bullfrog vascular smooth muscle regulate the hypotensive effect and that they can be antagonized by ablukast. Ablukast has been in phase III clinical trials for the treatment of bowel disease. However, this research has been discontinued.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:21:49 GMT 2023
by
admin
on
Fri Dec 15 16:21:49 GMT 2023
|
Record UNII |
000TKM5BBQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29712
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20869277
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
C053877
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
100000082325
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
6441
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
57109
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
SUB07363MIG
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL22016
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
AA-71
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
C74132
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
000TKM5BBQ
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
96566-25-5
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY | |||
|
ABLUKAST
Created by
admin on Fri Dec 15 16:21:49 GMT 2023 , Edited by admin on Fri Dec 15 16:21:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER | |||
|
RACEMATE -> ENANTIOMER | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |